Clinical Trial Evaluating Methotrexate or Leflunomide + Targeted Therapy Versus Methotrexate or Leflunomide + Sulfasalazine + Hydroxychloroquine in Patients With Rheumatoid Arthritis and Insufficient Response to Methotrexate or Leflunomide

Clinical trial NCT02714634 · RECRUITING

Trial details

NCT number: NCT02714634
Sponsor: University Hospital, Strasbourg, France
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Rheumatoid Arthritis Insufficient Response to Methotrexate or Leflunomide

Start date: 2016-03-30
Primary completion: 2029-03-01
Enrollment: 286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.